T1	KeyEntity 93 119	Collagen-induced arthritis
T2	Entity 161 191	autoimmune experimental models
T3	KeyEntity 219 239	rheumatoid arthritis
T4	KeyEntity 247 273	collagen-induced arthritis
T5	Entity 287 304	polygenic disease
T6	Entity 357 382	disease-controlling genes
T7	Entity 392 412	rheumatoid arthritis
T8	KeyEntity 519 545	collagen-induced arthritis
T9	Entity 594 599	NFR/N
T10	Entity 604 609	B10.Q
T11	Entity 611 625	H-2q haplotype
T13	Entity 859 881	microsatellite markers
T15	Entity 951 970	arthritis incidence
T16	Entity 972 980	severity
T17	Entity 1001 1014	chromosome 11
T18	KeyEntity 1024 1029	Cia40
T19	Entity 1038 1049	colocalizes
T20	Entity 1075 1092	pregnancy failure
T22	Entity 1181 1190	incidence
T23	Entity 1192 1200	severity
T24	Entity 1205 1217	day of onset
T25	Entity 1236 1248	chromosome 1
T27	Entity 1327 1359	collagen type II antibody titers
T28	Entity 1378 1391	chromosome 13
T29	Entity 1427 1436	gene loci
T30	Entity 1445 1454	arthritis
T31	Entity 1458 1482	aged multiparous females
T32	Entity 1535 1552	pregnancy failure
R1	participates_in Arg1:T1 Arg2:T2	
R2	participates_in Arg1:T3 Arg2:T2	
R3	is_part_of Arg1:T4 Arg2:T5	
R4	is_part_of Arg1:T10 Arg2:T11	
R5	is_part_of Arg1:T9 Arg2:T11	
R6	is_subclass_of Arg1:T8 Arg2:T7	
R7	participates_in Arg1:T17 Arg2:T15	
R8	participates_in Arg1:T17 Arg2:T16	
T14	Entity 985 997	day of onset
R9	participates_in Arg1:T17 Arg2:T14	
R10	is_part_of Arg1:T17 Arg2:T18	
R11	participates_in Arg1:T18 Arg2:T20	
R12	participates_in Arg1:T22 Arg2:T25	
R13	participates_in Arg1:T23 Arg2:T25	
R14	participates_in Arg1:T24 Arg2:T25	
R15	participates_in Arg1:T27 Arg2:T28	
R16	regulates Arg1:T29 Arg2:T30	
R17	participates_in Arg1:T29 Arg2:T32	
T21	KeyEntity 18 49	collagen-induced arthritis loci
T26	Entity 53 81	aged multiparous female mice
R18	is_part_of Arg1:T21 Arg2:T26	
T12	Entity 828 849	genome-wide screening
T33	KeyEntity 1594 1619	rheumatoid arthritis (RA)
T34	KeyEntity 1631 1663	collagen-induced arthritis (CIA)
T35	KeyEntity 1769 1771	RA
T36	Entity 1789 1794;1798 1814	women reproductive age
R19	is_part_of Arg1:T35 Arg2:T36	
T37	KeyEntity 1947 1949	RA
T38	Entity 1958 1976	clinical remission
T39	Entity 1903 1909	female
R20	is_part_of Arg1:T37 Arg2:T39	
R21	interacts_with Arg1:T38 Arg2:T39	
T40	Entity 1998 2007	pregnancy
R22	participates_in Arg1:T38 Arg2:T40	
T41	KeyEntity 2072 2074	RA
T42	Entity 2170 2180	postpartum
T43	Entity 2135 2144	pregnancy
T44	KeyEntity 2254 2256	RA
T45	Entity 2459 2481	complex human diseases
T46	Entity 2384 2397	animal models
T47	KeyEntity 2483 2486	CIA
T48	Entity 2507 2520;2538 2553	immunological characteristics
T49	Entity 2525 2553	pathological characteristics
T50	KeyEntity 2559 2567	human RA
T51	KeyEntity 2662 2671	arthritis
R23	is_part_of Arg1:T50 Arg2:T51	
T52	KeyEntity 2690 2693	CIA
T53	Entity 2697 2710	sex dependent
R24	regulates Arg1:T53 Arg2:T52	
T54	KeyEntity 2734 2736	RA
T55	Entity 2757 2764	species
T56	Entity 2779 2787;2795 2802	variants disease
T57	Entity 2822 2826;2838 2850	male predominance
T58	Entity 2831 2850	female predominance
T59	Entity 2900 2918	Gender differences
T60	KeyEntity 2922 2925	CIA
T61	Entity 2982 2989;3015 3025	genetic influences
T62	Entity 2991 2999;3015 3025	hormonal influences
T63	Entity 3004 3024	behavioral influence
T64	KeyEntity 3091 3093	RA
T65	Entity 3193 3202;3206 3215	remission arthritis
T66	Entity 3133 3142;3146 3150	Pregnancy mice
R25	regulates Arg1:T66 Arg2:T65	
T67	Entity 3230 3242	exacerbation
T68	Entity 3256 3266	postpartum
T69	Entity 3278 3305	Pregnancy-induced remission
T70	KeyEntity 3309 3312	CIA
R26	regulates Arg1:T69 Arg2:T70	
T71	Entity 3349 3357;3361 3376	increase estrogen levels
R27	regulates Arg1:T70 Arg2:T71	
T72	Entity 3388 3411	postpartum exacerbation
T73	Entity 3445 3449;3453 3461	drop estrogen
R28	regulates Arg1:T73 Arg2:T72	
T74	Entity 3491 3517	increased prolactin levels
T75	KeyEntity 3595 3598	CIA
T76	KeyEntity 3678 3680	RA
T77	Entity 4100 4112	N2 backcross
T78	Entity 4121 4126	NFR/N
T79	Entity 4131 4150	C57BL/B10.Q (B10.Q)
T80	KeyEntity 4176 4191;4195 4198	genetic control CIA
T81	Entity 4273 4290	Inbred NFR/N mice
T82	Entity 4382 4387	B10.Q
T83	Entity 4467 4491	(B10Q × NFR/N)F1 hybrids
T84	Entity 4496 4511	(B10.Q × NFR/N)
T85	Entity 4514 4522	B10.Q N2
T86	Entity 4706 4716	ad libitum
T87	Entity 5238 5266	N2 backcross (B10.Q × NFR/N)
T88	Entity 5269 5274	B10.Q
T89	Entity 5442 5456	B10.RIII males
T90	Entity 5458 5475	allogeneic mating
T91	Entity 5488 5526	MHC (major histocompatibility complex)
T92	Entity 5558 5569	B10.Q males
T93	Entity 5571 5587	syngeneic mating
T94	Entity 5600 5603	MHC
T95	KeyEntity 5638 5641	CIA
T96	KeyEntity 5703 5706	CIA
T97	KeyEntity 5718 5721	CIA
T98	Entity 5747 5761	subcutaneously
T99	Entity 5798 5824	rat collagen type II (CII)
T100	Entity 5845 5856	acetic acid
T101	Entity 5899 5915	Freud's adjuvant
T102	Entity 5993 5996	CII
T103	Entity 6017 6028	acetic acid
T104	Entity 6062 6089	Freud's incomplete adjuvant
T105	Entity 6160 6169	arthritis
T106	Entity 6262 6265	CIA
T107	Entity 6328 6343	arthritis index
T108	Entity 6401 6402;6405 6407;6424 6433	0 no arthritis
T109	Entity 6435 6436;6439 6446;6451 6459;6465 6477	1 redness swelling single joint
T110	Entity 6479 6480;6483 6495;6499 6514	2 inflammation multiple joints
T111	Entity 6520 6521;6524 6543	3 severe inflammation
T112	KeyEntity 6840 6849	arthritis
R29	interacts_with Arg1:T99 Arg2:T98	
R30	interacts_with Arg1:T100 Arg2:T99	
R31	interacts_with Arg1:T101 Arg2:T99	
R32	interacts_with Arg1:T103 Arg2:T102	
R33	interacts_with Arg1:T104 Arg2:T103	
T113	Entity 6881 6906	Microsatellite genotyping
T114	Entity 6911 6927	linkage analysis
T115	Entity 6967 6977	N2 females
T116	Entity 6986 6999	F0 generation
T117	Entity 6929 6942	Tail biopsies
R34	is_part_of Arg1:T117 Arg2:T115	
T118	Entity 7124 7173	mouse fluorescence-labeled microsatellite markers
T119	Entity 7291 7298	N2 mice
T120	Entity 7381 7398	PCR amplification
T121	Entity 7461 7494	96-well V-bottom microtiter plate
T122	Entity 7507 7510	DNA
T123	Entity 7518 7521	KCl
T124	Entity 7529 7537	Tris–HCl
T125	Entity 7545 7554	(NH4)2SO4
T126	Entity 7561 7566	MgCl2
T127	Entity 7573 7593	Triton X-100, pH 8.8
T128	Entity 7673 7678	dNTPs
T129	Entity 7736 7754	Taq DNA Polymerase
T130	Entity 7834 7854	denaturation at 95°C
T131	Entity 7870 7887	annealing at 56°C
T132	Entity 7904 7926	polymerization at 72°C
T133	Entity 7941 7958	30 cycles of 95°C
T134	Entity 8103 8117	MegaBACE™ 1000
T135	Entity 8293 8325	Map Manager QTXb20 free software
T136	Entity 8351 8367	linkage analysis
T137	Entity 8376 8392	permutation test
T138	Entity 8448 8468	intermarker distance
T139	Entity 8474 8484	marker map
T140	Entity 8509 8530	Kosambis map function
T141	Entity 8605 8622	permutation tests
T142	Entity 8898 8914	Interval mapping
T143	Entity 8955 8980	additive regression model
T144	Entity 9025 9058	Enzyme-linked immunosorbent assay
T146	Entity 9122 9126	sera
T145	Entity 9143 9167	Anti-CII antibody titers
T147	Entity 9171 9175	sera
R35	is_part_of Arg1:T145 Arg2:T147	
T148	Entity 9195 9219	sandwich ELISA technique
T149	KeyEntity 9236 9239	CII
T150	Entity 9266 9286	immunosorbent plates
T151	Entity 9305 9325	Bovine serum albumin
T152	Entity 9422 9434	control sera
T153	Entity 9436 9470	purified mouse anti-CII antibodies
T154	Entity 9473 9482	test sera
T155	Entity 9547 9563	CII-specific IgG
T156	Entity 9591 9631	peroxidase-conjugated goat antimouse IgG
R36	interacts_with Arg1:T156 Arg2:T155	
R37	interacts_with Arg1:T150 Arg2:T149	
T157	Entity 9745 9764	Mann-Whitney U test
T158	Entity 9805 9822	NFR/N female mice
T159	Entity 9828 9841	delayed onset
T160	KeyEntity 9846 9861;9866 9867	lower incidence I
T161	Entity 9883 9896	B10.Q females
T162	Entity 9952 9962	NFR/N mice
T163	Entity 10080 10089	arthritis
T164	Entity 10138 10148	NFR/N mice
T165	Entity 10211 10221	B10.Q mice
T166	Entity 10159 10175;10179 10187	higher frequency swelling
R38	is_part_of Arg1:T166 Arg2:T164	
T167	KeyEntity 10270 10283	CIA frequency
T168	Entity 10349 10364	anti-CII titers
T169	Entity 10380 10400	primary immunization
T170	Entity 10464 10469;10480 10491	NFR/N female mice
T171	Entity 10474 10491	B10.Q female mice
T172	KeyEntity 10569 10577;10581 10584	severity CIA
T173	Entity 10508 10525	Pregnancy history
R39	other_relation Arg1:T173 Arg2:T172	
#1	AnnotatorNotes R39	no_relation
T174	Entity 10588 10599	female mice
R40	is_part_of Arg1:T173 Arg2:T174	
T175	Entity 10661 10680	arthritic incidence
T176	Entity 10682 10697	arthritis onset
T177	Entity 10702 10725	maximum arthritic score
T178	Entity 10753 10791	N2 generation, (NFR/N × B10.Q) × B10.Q
T179	KeyEntity 10888 10891	CII
T180	Entity 10949 10957;10961 10970	severity arthritis
T181	Entity 10988 11009	number of pregnancies
R41	other_relation Arg1:T180 Arg2:T181	
#2	AnnotatorNotes R41	no_relation
T182	Entity 11099 11112	ower severity
T183	Entity 11116 11132	multiparous mice
R42	interacts_with Arg1:T183 Arg2:T182	
T184	Entity 11401 11432	MHC mismatched males (B10.RIII)
T185	Entity 11483 11508	MHC matched males (B10.Q)
T186	KeyEntity 11536 11539	CIA
T187	Entity 11575 11599	genetic linkage analysis
T188	Entity 11625 11655	quantitative trait locus (QTL)
T189	Entity 11667 11692	64–70 cM on chromosome 11
T190	Entity 11737 11742	Cia40
T191	Entity 11761 11771	LOD scores
T192	Entity 11798 11801	LOD
T193	Entity 11829 11832	LOD
T194	Entity 11780 11796	traits incidence
T195	Entity 11814 11826	day of onset
T196	Entity 11858 11867	LOD score
T197	Entity 11883 11898	arthritis score
T198	Entity 11901 11904	LOD
T199	Entity 11921 11924	QTL
T200	Entity 12003 12024	27 cM on chromosome 1
T201	Entity 12059 12062	QTL
T202	Entity 12077 12100	anti-CII antibody titer
T203	Entity 12119 12132	chromosome 13
R43	participates_in Arg1:T202 Arg2:T203	
R44	participates_in Arg1:T188 Arg2:T189	
R45	participates_in Arg1:T199 Arg2:T200	
T204	KeyEntity 12185 12211	CIA-susceptible MHC region
T205	Entity 12217 12222	NFR/N
T206	Entity 12227 12237	B10.Q mice
T207	Entity 12277 12288	NFR/N mouse
T208	Entity 12303 12319;12327 12341	nbred NMRI mouse H-2q haplotype
R46	is_part_of Arg1:T208 Arg2:T207	
T209	Entity 12370 12381	B10.Q mouse
T210	Entity 12424 12448	good breeding properties
R47	is_part_of Arg1:T210 Arg2:T207	
T211	Entity 12486 12517	(NFR/N × B10.Q) × B10.Q females
T212	KeyEntity 12811 12814	CIA
T213	Entity 12844 12869	MHC class II A beta genes
T214	Entity 12898 12912;12917 12936	susceptibility nflammatory disease
T215	Entity 13019 13034;13038 13047	genetic control arthritis
T216	KeyEntity 13099 13107	human RA
T217	KeyEntity 13326 13334;13338 13341	severity CIA
T218	Entity 13366 13382	linkage analyses
T219	Entity 13410 13429	CIA-associated loci
T220	Entity 13514 13530	multiparous mice
T221	KeyEntity 13544 13546	RA
T222	Entity 13609 13621	NFR/N strain
T223	Entity 13654 13670	linkage analyses
T224	Entity 13688 13707	CIA-associated loci
T225	Entity 13760 13777	polymorphic genes
R48	is_part_of Arg1:T215 Arg2:T216	
R49	interacts_with Arg1:T218 Arg2:T219	
T226	Entity 13862 13873	multiparity
T227	KeyEntity 13921 13929;13933 13936	severity CIA
R50	other_relation Arg1:T226 Arg2:T227	
#3	AnnotatorNotes R50	no_relation
T228	KeyEntity 14027 14029	RA
T229	Entity 14071 14090;14094 14103	previous experience pregnancy
T230	KeyEntity 14148 14156;14160 14162	severity RA
R51	other_relation Arg1:T229 Arg2:T230	
#4	AnnotatorNotes R51	no_relation
T231	Entity 14278 14287	arthritis
T232	Entity 14318 14337;14345 14352	temporary remission disease
T233	Entity 14393 14411	exacerbation phase
T234	KeyEntity 14517 14520	CIA
T235	Entity 14561 14585;14587 14600	arthritis susceptibility chromosomes 1
T236	Entity 14561 14585;14587 14598;14605 14607	arthritis susceptibility chromosomes 11
T237	Entity 14633 14664	anti-CII titers (chromosome 13)
T238	Entity 14671 14685	arthritis loci
T239	Entity 14721 14733	chromosome 1
R52	participates_in Arg1:T238 Arg2:T239	
T240	Entity 14735 14748	Cia15 at 8 cM
T241	Entity 14755 14769	Cia20 at 44 cM
T242	Entity 14779 14792	Cia9 at 92 cM
T243	Entity 14869 14881	chromosome 1
T244	Entity 14925 14936	Cia40 locus
T245	Entity 14950 14968	Ctla4 (CD152) gene
R53	is_part_of Arg1:T245 Arg2:T244	
T246	Entity 15014 15034	spontaneous diabetes
R54	interacts_with Arg1:T244 Arg2:T246	
T247	Entity 15065 15070	C57Bl
T248	Entity 15075 15099	nonobese diabetic strain
T249	KeyEntity 15119 15122	CIA
T250	Entity 15230 15242	polymorphism
T251	Entity 15254 15259	Cia40
T252	Entity 15299 15307	diabetes
T253	Entity 15381 15386	Cia28
T254	Entity 15404 15432;15436 15441	anti-CII antibody production 53 cM
R55	interacts_with Arg1:T253 Arg2:T254	
T255	Entity 15445 15458	chromosome 13
R56	participates_in Arg1:T254 Arg2:T255	
T256	Entity 15612 15615	QTL
T257	Entity 15638 15651	chromosome 13
T258	Entity 15667 15672	Cia28
T259	Entity 15729 15741	chromosome 1
T260	Entity 15808 15821	chromosome 13
T261	Entity 15834 15839	Cia28
T262	Entity 15896 15899	QTL
T263	Entity 15904 15907	CIA
T264	Entity 15942 15955	chromosome 11
T265	Entity 15965 15970	Cia40
R57	participates_in Arg1:T265 Arg2:T264	
R58	participates_in Arg1:T261 Arg2:T260	
T266	Entity 15982 15991	CIA genes
T267	Entity 16059 16072	chromosome 11
T268	Entity 16105 16122	inflammation loci
R59	participates_in Arg1:T268 Arg2:T267	
T269	Entity 16132 16137	Eae22
T270	Entity 16139 16144	Eae6b
T271	Entity 16146 16151	Eae23
T272	Entity 16156 16160	Eae7
R60	is_subclass_of Arg1:T269 Arg2:T268	
R61	is_subclass_of Arg1:T270 Arg2:T268	
R62	is_subclass_of Arg1:T271 Arg2:T268	
R63	is_subclass_of Arg1:T272 Arg2:T268	
T273	Entity 16174 16177	QTL
T274	Entity 16182 16212	proteoglycan-induced arthritis
T275	Entity 16283 16296	chromosome 11
T276	Entity 16319 16325	Pgia28
T277	Entity 16361 16366	Cia40
T278	Entity 16398 16417	mouse chromosome 11
T279	Entity 16472 16491	human chromosome 17
R64	regulates Arg1:T279 Arg2:T278	
#5	AnnotatorNotes R64	homolog
T280	KeyEntity 16506 16514	human RA
T281	Entity 16592 16596	Cia5
T282	Entity 16616 16629	chromosome 10
R65	participates_in Arg1:T281 Arg2:T282	
T283	Entity 16651 16666	severity of CIA
T284	Entity 16671 16697	pristane-induced arthritis
R66	regulates Arg1:T281 Arg2:T283	
R67	regulates Arg1:T281 Arg2:T284	
T285	Entity 16796 16799	QTL
T286	Entity 16808 16814	Pregq2
T287	Entity 16830 16849	pregnancy frequency
T288	Entity 16878 16883	Cia40
T289	Entity 16893 16918	64–70 cM on chromosome 11
R68	participates_in Arg1:T288 Arg2:T289	
T290	Entity 17066 17081;17086 17099	genes affecting CIA incidence
T291	Entity 17103 17119	multiparous mice
R69	is_part_of Arg1:T290 Arg2:T291	
T292	Entity 17368 17386	inflammatory cause
T293	Entity 17306 17329	early pregnancy failure
R70	interacts_with Arg1:T292 Arg2:T293	
T294	Entity 17496 17507	multiparity
T295	Entity 17555 17570	severity of CIA
R71	other_relation Arg1:T294 Arg2:T295	
#6	AnnotatorNotes R71	no_relation
T296	KeyEntity 17630 17648	CIA susceptibility
T297	Entity 17666 17687	chromosome 11 (Cia40)
T298	Entity 17695 17707	chromosome 1
R72	participates_in Arg1:T296 Arg2:T297	
R73	participates_in Arg1:T296 Arg2:T298	
T299	Entity 17724 17737	chromosome 13
T300	Entity 17762 17777	anti-CII titers
T301	Entity 17831 17836	Cia28
R74	participates_in Arg1:T300 Arg2:T299	
T302	KeyEntity 17859 17862;17865 17891	CIA collagen-induced arthritis
T303	KeyEntity 17893 17896;17899 17915	CII collagen type II
T304	Entity 17917 17920;17923 17944	LOD logarithm of the odds
T305	Entity 17946 17949;17952 17984	MHC major histocompatibility complex
T306	Entity 17986 17989;17992 18017	PCR polymerase chain reaction
T307	Entity 18019 18022;18025 18049	QTL quantitative trait locus
T308	Entity 18051 18053;18056 18076	RA rheumatoid arthritis
T309	Entity 18683 18705	incidence of arthritis
T310	Entity 18731 18736	NFR/N
T311	Entity 18741 18746	B10.Q
R75	is_part_of Arg1:T309 Arg2:T310	
R76	is_part_of Arg1:T309 Arg2:T311	
T312	Entity 18775 18796	Chromosomal locations
T313	Entity 18804 18833	quantitative trait loci (QTL)
T314	Entity 18838 18864	collagen-induced arthritis
T315	Entity 18878 18891	chromosomes 1
T316	Entity 18878 18888;18896 18898	chromosome 11
T317	Entity 18900 18903	QTL
T318	Entity 18908 18946	collagen type II (CII) antibody titers
R77	is_part_of Arg1:T313 Arg2:T314	
R78	participates_in Arg1:T314 Arg2:T316	
R79	regulates Arg1:T314 Arg2:T315	
T319	Entity 18966 18979	chromosome 13
R80	participates_in Arg1:T318 Arg2:T319	
T320	Entity 19167 19188	Severity of arthritis
T321	Entity 19193 19232	anti-collagen type II (anti-CII) titers
T322	Entity 19237 19250	NFR/N × B10.Q
T323	Entity 19254 19271	B10.Q female mice
T324	Entity 19352 19366	arthritic mice
T325	Entity 19485 19499	arthritic mice
T326	Entity 19556 19566	B10.Q mice
T327	Entity 19657 19670	NFR/N × B10.Q
T328	Entity 19674 19691	B10.Q female mice
T329	Entity 19751 19765	arthritic mice
T330	Entity 19875 19889	arthritic mice
T331	Entity 19994 20001	N2 mice
T332	Entity 20053 20079	collagen-induced arthritis
